TRAITEMENT DE LA PNEUMOPATHIE NOSOCOMIALE :
EVOLUTION DU PATIENT
70. DE FÈS, A.C.H.I., LES PNEUMOPATHIES NOSOCOMIALES EN MILIEU DE RÉANIMATION
71. Ezzouine, H., N. Harbouze, and A. Benslama, E-14: Pneumopathies nosocomiales chez les patients séjournant au long cours en réanimation: caractéristiques cliniques et bactériologiques. Médecine et Maladies Infectieuses, 2014. 44(6): p. 39.
72. Zhang, Z. and J. Duan, Nosocomial pneumonia in non-invasive ventilation patients: incidence, characteristics, and outcomes. Journal of Hospital Infection, 2015. 91(2): p. 153-157.
73. Leal-Noval, S., Má rquez-Vacaro JA, Garcıa-Curiel A, Camacho-Larana P, Rincó n-Ferrari MD, Ordónez-Fernández A, et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med, 2000. 28: p. 935-40.
74. Dombret, M.-C., Pneumopathies nosocomiales chez le patient non immunodéprimé. EMC-Pneumologie, 2004. 1(2): p. 69-86.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
148
75. MEHDAOUI, S., Pneumopathies nosocomiales: Facteurs de risque et antibiorésistance des bactéries isolées. 2010.
76. Barie, P.S., Importance, morbidity, and mortality of pneumonia in the surgical intensive care unit. The American Journal of Surgery, 2000. 179(2): p. 2-7.
77. Said, S., Les infections nosocomiales dans le service de chirurgie B de l’hôpital du point G. Université du Mali: thèse de Doctorat, 2005.
78. Costa, Y., et al., Etude comparative quantitative entre examen microscopique et culture des prélèvements pulmonaires distaux protégés. Médecine et maladies infectieuses, 1996. 26: p. 618-623.
79. Raoof, S. and M.H. Baumann, An official multi-society statement: ventilator-associated events: the new definition. Chest, 2014. 145(1): p. 10-12.
80. Fagon, J.-Y., et al., Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. American Review of Respiratory Disease, 1989. 139(4): p. 877-884.
81. Langer, M., et al., Long-term respiratory support and risk of pneumonia in critically III patients. American review of respiratory disease, 1989. 140(2): p. 302-305.
82. Dodek, P., et al., Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Annals of Internal Medicine, 2004. 141(4): p. 305-313.
83. Meduri, G.U.-t. and J. Chastre, The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Infection Control & Hospital Epidemiology, 1992.
13(11): p. 640-649.
84. Bregeon, F., et al., Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia. Jama, 1997. 277(8): p. 655-662.
85. Alvarez-Lerma, F. and I.-A.P.S. Group, Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive care medicine, 1996. 22(5): p. 387-394.
86. Rello, J., et al., Pneumonia in intubated patients: role of respiratory airway care. American journal of respiratory and critical care medicine, 1996. 154(1): p. 111-115.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
149
87. Torres, A., et al., Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. American journal of respiratory and critical care medicine, 1995. 152(1): p. 137-141.
88. de Lassence, A., et al., Impact of Unplanned Extubation and Reintubation after Weaning on Nosocomial Pneumonia Risk in the Intensive Care UnitA Prospective Multicenter Study. Anesthesiology: The Journal of the American Society of Anesthesiologists, 2002. 97(1): p. 148-156.
89. Holzapfel, L., et al., Influence of long-term oro-or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Critical care medicine, 1993. 21(8): p. 1132-1138.
90. Djedaini, K., et al., Changing heat and moisture exchangers every 48 hours rather than 24 hours does not affect their efficacy and the incidence of nosocomial pneumonia. American journal of respiratory and critical care medicine, 1995. 152(5): p. 1562-1569.
91. Kieninger, A.N. and P.A. Lipsett, Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment. Surgical Clinics of North America, 2009. 89(2): p. 439-461. 92. Shan, L., et al., Relationship between antacid therapy and hospital acquired
pneumonia in critically ill patients: a meta-analysis. 2013.
93. Guillemot, D. and R. Leclercq, Impact de l'exposition des populations sur le risque de résistance bactérienne. Médecine et maladies infectieuses, 2005. 35: p. S212-S220. 94. Li, J., et al., Oral topical decontamination for preventing ventilator-associated
pneumonia: a systematic review and meta-analysis of randomized controlled trials. Journal of Hospital Infection, 2013. 84(4): p. 283-293.
95. Lorente, L., et al., Tracheal suction by closed system without daily change versus open system. Intensive care medicine, 2006. 32(4): p. 538-544.
96. Mahul, P., et al., Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive care medicine, 1992. 18(1): p. 20-25.
97. Kollef, M.H., N.J. Skubas, and T.M. Sundt, A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. CHEST Journal, 1999.
116(5): p. 1339-1346.
98. Iregui, M. and M.H. Kollef, Prevention of ventilator-associated pneumonia: selecting interventions that make a difference. CHEST Journal, 2002. 121(3): p. 679-681.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
150
99. Ntoumenopoulos, G., et al., Chest physiotherapy for the prevention of ventilator-associated pneumonia. Intensive care medicine, 2002. 28(7): p. 850-856.
100. Dezfulian, C., et al., Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. The American journal of medicine, 2005. 118(1): p. 11-18.
101. Lorente, L., et al., Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. American journal of respiratory and critical care medicine, 2007. 176(11): p. 1079-1083.
102. Lacherade, J.-C., et al., Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. American journal of respiratory and critical care medicine, 2010. 182(7): p. 910-917.
103. Aissaoui, Y., et al. Délai de la trachéotomie et devenir des patients sous ventilation mécanique. in Annales francaises d'anesthesie et de reanimation. 2007. Elsevier. 104. Jerassy, Z., et al., Prospective hospital-wide studies of 505 patients with nosocomial
bacteraemia in 1997 and 2002. Journal of Hospital Infection, 2006. 62(2): p. 230-236. 105. Sánchez-Velázquez, L.D., S.P. de León Rosales, and M.S.R. Frausto, The burden of
nosocomial infection in the intensive care unit: effects on organ failure, mortality and costs. A nested case-control study. Archives of medical research, 2006. 37(3): p. 370-375.
106. Goiburu, M., et al., The impact of malnutrition on morbidity, mortality and length of hospital stay in trauma patients. Nutricion hospitalaria, 2006. 21(5).
107. Barr, J., et al., Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. CHEST Journal, 2004. 125(4): p. 1446-1457.
108. Marik, P.E. and G.P. Zaloga, Early enteral nutrition in acutely ill patients: a systematic review. Critical care medicine, 2001. 29(12): p. 2264-2270.
109. Heyland, D.K., et al., Nutrition support in the critical care setting: current practice in canadian ICUs--opportunities for improvement? Journal of Parenteral and Enteral Nutrition, 2003. 27(1): p. 74-83.
110. Doig, G.S., et al., Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive care medicine, 2009. 35(12): p. 2018-2027.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
151
111. Artinian, V., H. Krayem, and B. DiGiovine, Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. CHEST Journal, 2006. 129(4): p. 960-967.
112. Khalid, I., P. Doshi, and B. DiGiovine, Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. American journal of critical care, 2010. 19(3): p. 261-268.
113. Casaer, M.P., et al., Early versus late parenteral nutrition in critically ill adults. N Engl J Med, 2011. 365(6): p. 506-517.
114. Moore, L.J., et al., Validation of a screening tool for the early identification of sepsis. Journal of Trauma and Acute Care Surgery, 2009. 66(6): p. 1539-1547.
115. Simpson, F. and G.S. Doig, Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive care medicine, 2005. 31(1): p. 12-23.
116. Mazuski, J.E., Feeding the injured intestine: enteral nutrition in the critically ill patient. Current opinion in critical care, 2008. 14(4): p. 432-437.
117. Braga, M., et al., Feeding the gut early after digestive surgery: results of a nine-year experience. Clinical Nutrition, 2002. 21(1): p. 59-65.
118. Gatt, M., et al., Changes in superior mesenteric artery blood flow after oral, enteral, and parenteral feeding in humans. Critical care medicine, 2009. 37(1): p. 171-176. 119. de Aguilar-Nascimento, J.E., D.B. Dock-Nascimento, and R. Bragagnolo, Role of
enteral nutrition and pharmaconutrients in conditions of splanchnic hypoperfusion. Nutrition, 2010. 26(4): p. 354-358.
120. Allen, J.M., Vasoactive substances and their effects on nutrition in the critically ill patient. Nutrition in Clinical Practice, 2012. 27(3): p. 335-339.
121. Scaife, C.L., J.R. Saffle, and S.E. Morris, Intestinal obstruction secondary to enteral feedings in burn trauma patients. Journal of Trauma and Acute Care Surgery, 1999.
47(5): p. 859.
122. Orozco-Levi, M., et al., Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. American journal of respiratory and critical care medicine, 1995. 152(4): p. 1387-1390.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
152
123. Drakulovic, M.B., et al., Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. The Lancet, 1999.
354(9193): p. 1851-1858.
124. Meduri, G.U., Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Critical Care, 2001. 6(1): p. 24.
125. van Nieuwenhoven, C.A., et al., Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Critical care medicine, 2006. 34(2): p. 396-402.
126. Liu, J., et al., Factors associated with low adherence to head-of-bed elevation during mechanical ventilation in Chinese intensive care units. Chinese medical journal, 2013.
126(5): p. 834-838.
127. Ibanez, J., et al., Gastroesophageal reflux in intubated patients receiving enteral nutrition: effect of supine and semirecumbent positions. Journal of Parenteral and Enteral Nutrition, 1992. 16(5): p. 419-422.
128. Ferrer, M., et al., Effect of nasogastric tube size on gastroesophageal reflux and microaspiration in intubated patients. Annals of internal medicine, 1999. 130(12): p. 991-994.
129. Cook, D.J., et al., Stress ulcer prophylaxis in critically III patients: resolving discordant meta-analyses. Jama, 1996. 275(4): p. 308-314.
130. Cook, D., et al., A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. New England Journal of Medicine, 1998. 338(12): p. 791-797.
131. Trémolières, F., et al., Faut-il développer de nouveaux antibiotiques? Médecine et maladies infectieuses, 2005. 35: p. S79-S86.
132. Sirvent, J.M., et al., Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. American journal of respiratory and critical care medicine, 1997. 155(5): p. 1729-1734.
133. Cohen, J., et al., Diagnosis of infection in sepsis: an evidence-based review. Critical care medicine, 2004. 32(11): p. S466-S494.
134. Andrews, C.P., et al., Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest, 1981. 80(3): p. 254-258.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
153
135. Bell, R.C., et al., Multiple organ system failure and infection in adult respiratory distress syndrome. Annals of internal medicine, 1983. 99(3): p. 293-298.
136. Determann, R.M., et al., Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive care medicine, 2005. 31(11): p. 1495-1500.
137. Fàbregas, N., et al., Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax, 1999.
54(10): p. 867-873.
138. Torres, A., et al., Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. American journal of respiratory and critical care medicine, 1994. 149(2): p. 324-331. 139. Wunderink, R.G., Radiologic diagnosis of ventilator-associated pneumonia. Chest
Journal, 2000. 117(4_suppl_2): p. 188S-190S.
140. Ioanas, M., et al., Microbial investigation in ventilator-associated pneumonia. European Respiratory Journal, 2001. 17(4): p. 791-801.
141. Fartoukh, M., et al., Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. American journal of respiratory and critical care medicine, 2003. 168(2): p. 173-179.
142. BLOT, F.O., et al., Value of Gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. American journal of respiratory and critical care medicine, 2000. 162(5): p. 1731-1737.
143. Fagon, J.-Y., et al., Invasive and noninvasive strategies for management of suspected ventilator-associated pneumoniaa randomized trial. Annals of internal medicine, 2000. 132(8): p. 621-630.
144. Pugin, J., et al., Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. American Review of Respiratory Disease, 1991. 143(5_pt_1): p. 1121-1129. 145. Luyt, C.-E., et al., Value of the clinical pulmonary infection score for the identification
and management of ventilator-associated pneumonia. Intensive care medicine, 2004.
30(5): p. 844-852.
146. Papazian, L., et al., Effect of ventilator-associated pneumonia on mortality and morbidity. American journal of respiratory and critical care medicine, 1996. 154(1): p. 91-97.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
154
147. Luna, C.M., et al., Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Critical care medicine, 2003. 31(3): p. 676-682.
148. Pieracci, F.M., et al., The relationship between body mass index and postoperative mortality from critical illness. Obesity surgery, 2008. 18(5): p. 501-507.
149. Mueller, E.W., et al., Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. Journal of Trauma and Acute Care Surgery, 2007.
63(6): p. 1329-1337.
150. Rouby, J.-J. Histology and microbiology of ventilator-associated pneumonias. in Seminars in respiratory infections. 1996.
151. Pham, L., et al., Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis, 1991. 143: p. 1055-61.
152. Luyt, C.-E., et al., Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. American journal of respiratory and critical care medicine, 2005. 171(1): p. 48-53.
153. Marr, J.J., H.L. Moffet, and C.M. Kunin, Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. The Journal of infectious diseases, 1988. 157(5): p. 869-876.
154. Shlaes, D.M., et al., Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance guidelines for the prevention of antimicrobial resistance in hospitals. Infection Control & Hospital Epidemiology, 1997. 18(4): p. 275-291.
155. Benhamou, D., A. Carrié, and F. Lecomte, Staphylococcus aureus: place et impact dans la prise en charge des pneumopathies nosocomiales. Revue des maladies respiratoires, 2005. 22(4): p. 595-603.
156. Lim, S.M. and S. Webb, Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance. Anaesthesia, 2005. 60(9): p. 887-902.
157. Goossens, H., et al., Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet, 2005. 365(9459): p. 579-587. 158. Peyrou, M., Antibiorésistance des souches bactériennes d'origine équine: étude
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
155
159. Joly-Guillou, M. and N. Hidri, Acinetobacter, Maîtrise des infections nosocomiales de A à Z. Editions HEALTH et CO, Paris, 2004.
160. Lahsoune, M., et al., Prévalence et état de sensibilité aux antibiotiques d'Acinetobacter baumannii dans un CHU marocain. Médecine et maladies infectieuses, 2007. 37(12): p. 828-831.
161. Bouchon, A., et al., TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature, 2001. 410(6832): p. 1103.
162. Garrabé, E., et al., Sensibilité aux antibiotiques des bactéries d'infections nosocomiales: Evolution dans les services de réanimation des hôpitaux des armées. La presse médicale, 2000. 29(27): p. 1497-1503.
163. Giard, M., et al., Comparaison des facteurs de risque et pronostic des pneumopathies nosocomiales précoces et tardives acquises en réanimation. Hygiènes Lyon, 2006. 14: p. 257-265.
164. HIND, M.Z., PNEUMOPATHIE NOSOCOMIALE (A propos de 60 cas).
165. Mastouri, M., et al., Résistance aux antibiotiques de Staphylococcus aureus résistant à la méticilline: détection des premières souches de sensibilité diminuée aux glycopeptides en Tunisie. Pathologie Biologie, 2006. 54(1): p. 33-36.
166. MAHTAR, H., Les pneumopathies nosocomiales à Pseudomonas aeruginosaétude rétrospective à l’hôpital militaire d’instruction Mohammed v de rabat (2007-2008). 2011.
167. Santé, A.F.d.S.S.d.P.d., Antibiothérapie par voie générale dans les infections respiratoires basses de l’adulte. Pneumonie aiguë communautaire. Exacerbations de bronchopneumopathie chronique obstructive, 2010.
168. Society, A.T., Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 2005. 171: p. 388-416.
169. Garnacho-Montero, J., et al., Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clinical Infectious Diseases, 2003.
36(9): p. 1111-1118.
170. Paul, M., et al., β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. Bmj, 2004. 328(7441): p. 668.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
156
171. Fagon, J.-Y., et al., Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. American journal of respiratory and critical care medicine, 2000. 161(3): p. 753-762.
172. Rubinstein, E., et al., Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clinical Infectious Diseases, 2001. 32(3): p. 402-412.
173. Masterton, R., et al., Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy, 2008. 62(1): p. 5-34.
174. Fagon, J.-Y., et al., Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. The American journal of medicine, 1993. 94(3): p. 281-288.
175. Fartoukh, M. and J.-D. Ricard, Pneumonies nosocomiales: aspects pratiques de la prise en charge. Revue des Maladies Respiratoires, 2009. 26(4): p. 463-467.
176. Montravers, P., et al., Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. American Review of Respiratory Disease, 1993. 147(1): p. 38-44.
177. Knaus, W.A., et al., APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Critical care medicine, 1981. 9(8): p. 591-597.
178. Ricard, J.-D., Prévention des pneumopathies acquises sous ventilation mécanique: comment l'améliorer?: D'aprés la communication de Jean-Damien Ricard. Reanimation, 2007. 16: p. S249-S252.
179. Hassoune, S., et al., Incidence des bactériémies nosocomiales dans les services à haut risque du centre hospitalier universitaire de Casablanca (Maroc). Pratiques et Organisation des Soins, 2012. 43(1): p. 19-24.
180. Alwan, A., et al., La Revue de Santé de la Méditerranée orientale. EMHJ, 2014.
20(5): p. 285-286.
181. Qassimi, L., Épidémiologie des infections nosocomiales en milieu de réanimation (A propos de 147 cas). 2010.
182. Heyland, D.K., et al., The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. American journal of respiratory and critical care medicine, 1999. 159(4): p. 1249-1256.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
157
183. Rello, J., et al., Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest Journal, 2002. 122(6): p. 2115-2121.
184. Yamane, K., et al., Global spread of multiple aminoglycoside resistance genes. Emerging infectious diseases, 2005. 11(6): p. 951.
185. Álvarez-Lerma, F., et al., Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study. Critical Care, 2006. 10(3): p. R78.
186. Kallel, H., et al., Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study. Intensive care medicine, 2007. 33(7): p. 1162-1167.
187. Lombrail, P., T. Lang, and J. Pascal, Accès au système de soins et inégalités sociales de santé: que sait-on de l’accès secondaire? Santé, société et solidarité, 2004. 3(2): p. 61-71.
188. Astagneau, P., et al., Comité technique national des infections nosocomiales. 100recommandations pour la surveillance et la prévention des infections nosocomiales. Paris: Éditions NHA Communication, 1999.
189. Astagneau, P. and G. Brücker, Coût des infections nosocomiales. Journal de pediatrie et de puericulture, 1998. 11(6): p. 348-353.
190. Daschner, F., Cost-effectiveness in hospital infection control—lessons for the 1990s. Journal of hospital infection, 1989. 13(4): p. 325-336.
191. Durand-Zaleski, I., C. Chaix, and C. Brun Buisson, Le coût des infections liées aux soins. Act Doss Santé Publique, 2002. 38: p. 29-31.
192. Klevens, R.M., et al., Estimating health care-associated infections and deaths in US hospitals, 2002. Public health reports, 2007. 122(2): p. 160-166.
193. Gaynes, R., The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infectious disease clinics of North America, 1997.
11(4): p. 757-765.
194. Girou, E., Comment diminuer en pratique les infections nosocomiales en réanimation? Réanimation, 2008. 17(3): p. 275-279.
195. ., R., Guide pour la prévention des infections nosocomiales en réanimation. 1994: Arnette.
Pneumopathies Nosocomiales en Réanimation a l’HMIMV : Caractéristiques Epidémiologiques, Cliniques, Bactériologiques et Impact économique
158
196. Nava, S., et al., Noninvasive Mechanical Ventilation in the Weaning of Patients with Respiratory Failure Due to Chronic Obstructive Pulmonary DiseaseA Randomized, Controlled Trial. Annals of internal medicine, 1998. 128(9): p. 721-728.
197. Fagon, J., C. Ract, and A. Novara, Prévention des pneumopathies acquises sous ventilation mécanique. Réanimation, 2001. 10(1): p. 61-70.
198. Pujol, M., et al., Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. European Journal of Clinical Microbiology & Infectious Diseases, 1998. 17(9): p. 622-628. 199. De, A.N.P.L.D., L’évaluation Médicale (Andem). Recommandations et références
médi-cales. Cystites et pyélonéphrites aiguës simples de la femme de 15 a 65 ans, en dehors de la grossesse. Concours Med, 1996. 40: p. 26-42.
200. Levent, T., et al., L'hygiène hospitalière et le conseil en antibiothérapie: un duo opérationnel face au problème de la diffusion des bactéries multirésistantes aux antibiotiques. Médecine et maladies infectieuses, 2005. 35(9): p. 443-449.